Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood

Transfusion

Volumn 53, Issue 4, 2013, Pages 860-867

  Tonnetti, Laura ^a   Thorp, Aaron M ^a   Reddy, Heather L ^a   Keil, Shawn D ^a   Goodrich, Raymond P ^a   Leiby, David A ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN;

ANIMAL EXPERIMENT; ARTICLE; BABESIA MICROTI; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; HAMSTER; HUMAN; ILLUMINATION; INOCULATION; MICROSCOPY; NONHUMAN; PILOT STUDY; PIROPLASMOSIS; PLASMAPHERESIS; POSTINOCULATION; ULTRAVIOLET RADIATION;

ANIMALS; BABESIA MICROTI; BABESIOSIS; BLOOD; BLOOD SAFETY; BLOOD TRANSFUSION; CRICETINAE; DNA, PROTOZOAN; FEMALE; HUMANS; PARASITE LOAD; PHOTOSENSITIZING AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 84876146438     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03791.x     Document Type: Article

References (23)

1. Menfis M, Anderson SA, Izurieta H, Kumar S, Burwen DR, Gibbs J, Kropp G, Erten T, Macurdy TE, Worrall CM, Kelman JA, Walderhaug MO,. Babesiosis among elderly Medicare beneficiaries, United States, 2006-2008. Emerg Infect Dis 2012; 18: 128-30.
2. Gubernot DM, Lucey CT, Lee KC, Conley GB, Holness LG, Wise RP,. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis 2009; 48: 25-30.
3. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M,. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155: 509-19.
4. Leiby DA,. Transfusion-transmitted babesia spp.: bull's-eye on Babesia microti. Clin Micro Rev 2011; 24: 14-8.
5. Joseph JT, Roy SS, Sham N, Visintainer P, Nadelman RB, Hosur S, Nelson J, Worrmser GP,. Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis 2011; 17: 843-7.
6. Vannier E, Krause PJ,. Update on babesiosis. Interdiscip Perspect Infec Dis 2009; 2009: 984568.
7. Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA,. Evaluation of the Mirasol reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion 2010; 50: 1019-27.
8. Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA,. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion 2012; 52: 409-16.
9. Goodrich RP, Doane S, Reddy HL,. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010; 38: 20-30.
10. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP,. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-85.
11. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R,. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006; 90: 85-91.
12. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R,. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007; 37: 131-7.
13. Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R,. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007; 47: 240-7.
14. Pantanowitz L, Cannon ME,. Extracellular Babesia microti parasites. Transfusion 2001; 41: 400.
15. Setty S, Khalil Z, Schori P, Azar A, Ferrieri P,. Two atypical cases from Minnesota and review. Am J Clin Pathol 2003; 120: 554-9.
16. Carter WJ, Yan Z, Cassai ND, Sidhu GS,. Detection of extracellular forms of Babesia in the blood by electron microscopy: a diagnostic method for differentiation from Plasmodium falciparum. Ultrastruct Pathol 2003; 27: 211-6.
17. Clark IA, Budd AC, Hsue G, Haymore BR, Joyce AL, Thorner R, Krouse P,. Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malar J 2006; 5: 69.
18. Wormser GP, Lombardo G, Silverblatt F, El Khoury M, Prasad A, Yelon JA, Sanda A, Karim S, Coku L, Savino JA,. Babesiosis as a cause of fever in patients undergoing a splenectomy. Am Surg 2011; 3: 345-7.
19. Abrams Y,. Complications of coinfection with babesia and Lyme disease after splenectomy. JABFM 2008; 21: 75-7.
20. White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL,. Human babesiosis in New York State. Arch Intern Med 1998; 158: 2149-54.
21. Leiby DA, Chung AP, Gill E, Houghton RL, Persing HD, Badon S, Cable RG,. Demonstrable parasitemia among Connecticut blood donors with antibody to Babesia microti. Transfusion 2005; 45: 1804-10.
22. Johnson ST, Cable RG, Tonnetti L, Spenser B, Rios J, Leiby DA,. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007. Transfusion 2009; 49: 2574-82.
23. Rasongles P, Angelini-Tibert MF, Simon P, Currie C, Isola H, Kientz D, Slaedts M, Jacquet M, Sundin D, Lin L, Corash L, Cazenave JP,. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Reunion. Transfusion 2009; 49: 1083-91.